ARCHIVES

Second Irregularity In NSABP Data Found; Fisher Takes Leave As Group’s Chairman

This article is from The Cancer Letter archive.

Vol. 20 No. 13 | April 1, 1994

Download PDF Visit The Full Archive

Related Articles

FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza

December 26, 2014

NCI Programs: BSA Approves Formation Of Two Grant Programs:

July 2, 1999

Expiring Program Offer Flexibility

February 12, 1982

Klausner Reaffirms NCI’s “No. 1 Priority” Is Funding investigator-Initiated Research

September 13, 1996

Duke Insiders Allege Intimidation By Administration

July 23, 2010

Beckman Coulter Offers Immunoassay System.

July 27, 2001